lead plaintiff deadline

Securities lawsuit filed against $ATRA over alleged false statements on manufacturing issues and ALLELE study deficiencies affecting tabelecleucel approval prospects.

Class action lawsuit filed against Boston Scientific for allegedly concealing unsustainable growth in U.S. Electrophysiology segment. Affected investors have until May 4, 2026 deadline.

Rosen Law Firm urges LAKE investors with losses exceeding $100K to join securities lawsuit by April 24, 2026 deadline, alleging Lakeland Industries misrepresented operational issues with Pacific Helmets and Jolly divisions.

PSIX faces securities class action for allegedly misrepresenting data center sales capture ability and understating manufacturing costs. Investor deadline May 19, 2026.

Rosen Law Firm sues Aldeyra Therapeutics for false reproxalap trial claims. Lead plaintiff deadline: May 29, 2026.

Three companies face shareholder class actions alleging material misstatements on clinical trials, operations, and expenses. Lead plaintiff deadlines set for April 2026.

Securities lawsuit filed against ODDITY Tech for allegedly misrepresenting business impact of advertising partner's algorithm change. Investors have until May 11, 2026 to join.

NuScale Power faces securities class action alleging misrepresentations about strategic partner ENTRA1 Energy's nuclear experience. April 20, 2026 deadline applies.

Class action lawsuit filed against $SNOW for allegedly concealing negative revenue impact of product efficiency features. Investors have until April 2026 deadline.

Rosen Law Firm alerts Gartner investors about securities class action alleging false statements on growth targets between February 2025-2026, with May 18 deadline for lead plaintiff claims.

Class action lawsuit filed against $PINS for allegedly misleading investors about advertising revenues and tariff impacts. Lead plaintiff deadline set for May 29, 2026.

Rosen Law Firm urges $CIGL investors to act before May 20, 2026 lead plaintiff deadline in securities class action alleging false statements and fraudulent stock promotion.

Pomerantz Law Firm filed class action against $AMC over alleged securities fraud regarding APE preferred equity units excluded from special dividend. Investors must act by April 20, 2026.

PomDoctor stock plummeted 91% to $0.50 from $6.09 amid pump-and-dump fraud allegations. Pomerantz Law Firm filed class action; investors have until April 6, 2026 to claim losses.

Rosen Law Firm files securities class action against ImmunityBio alleging false statements about Anktiva capabilities, recruiting lead plaintiffs.

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about financial metrics from April 2025 to February 2026.

Lufax Holding Ltd. ($LU) stock plunged 13.8% after PwC flagged material misstatements in 2022-2023 financial reports, triggering class action litigation.

Rosen Law Firm urges $PMI investors to join class action alleging false statements, social media misinformation, and insider share dumping. Lead plaintiff deadline: April 13, 2026.

Rosen Law Firm urges $ALIT investors to join securities class action alleging false growth statements and undisclosed dividend sustainability issues.

Rosen Law Firm alerts $COTY investors of May 22 deadline in securities lawsuit alleging false statements on growth, margins, and segment performance.